Frequency Exchange Corp (TSXV:FREQ)(OTC PINK:FRECF) announced that CEO Stephen Davis will present at the 2024 Quantum Leap Into Health Conference alongside Dr. Keith Pyne, discussing NIKKI's effectiveness in treating Lyme Disease. Dr. Pyne, a medical advisor to major sports organizations including MLB, NBA, NHL, and NFL, personally experienced success with NIKKI Wearable Wellness Technology in treating his Lyme disease. After using NIKKI's Lyme Program for 10 months, Dr. Pyne's test results showed complete eradication of Lyme disease markers by May 17, 2018. Following his recovery, he joined the company's Board in 2019.
Frequency Exchange Corp (TSXV:FREQ)(OTC PINK:FRECF) has launched its NIKKI Wellness Technology on GetHealthy.Store's virtual catalogue, reaching over 1,000 Virtual Clinic Stores. The platform serves more than 2,500 health practitioners across the United States.
Through this partnership, doctors can prescribe NIKKI along with tailored Wellness Programs directly to patients. GetHealthy.Store will handle distribution, fulfillment, customer service, and marketing in the USA and 25 additional countries. The agreement enables FREmedica to scale production up to 1,000,000 NIKKI devices every 90-120 days.
NIKKI is a wearable device that utilizes bioenergetics for health and wellbeing, offering programs for sleep improvement, pain relief, anxiety reduction, and energy boosting.
Frequency Exchange Corp (TSXV:FREQ)(OTC PINK:FRECF) announces that former NHL star and current Boston Bruins President Cam Neely is joining its Advisory Board. Neely, a Hockey Hall of Fame inductee who played for the Vancouver Canucks and Boston Bruins from 1983-96, will provide strategic guidance as the company expands its NIKKI Wellness Technology sales in the US and Canada. Neely, who has personal experience with the company's frequency therapy technology helping his family manage Lyme disease symptoms, expressed enthusiasm about helping more people discover its health benefits, particularly in sports applications.